Peptivius / Blueprint / Home
Plan

Welcome back, Ana.

Every transformation is built in days like this.

12
dossier scopeactive niches
80
evaluated librarypeptides ranked
Elite
access tierpersonalized tier
Apr 23, 2026
generated dateblueprint timestamp
active focus areas
Weight Loss7Recovery & Healing5Performance & Muscle13Gut Health6Longevity6Immune Support6Sleep & Rest5Focus & Cognition5
Open Daily Log
today calendarJun 14, 2026
SMTWTFS
311234567891011121314151617181920212223242526272829301234567891011
today status

What needs attention now

0Due today
0Logged
0Skipped / missed
next plannedNo active plan event
Weight Loss niche visual
niche focusWeight Loss

Four primary compounds and three secondary options carried forward for the Weight Loss report surface.

7peptides evaluated3strong matches
TirzepatideSemaglutideRetatrutideTesamorelinLiraglutide

Syringe calculator

010203040500 UI50 UI
Open

Body map

Open
plans
0active plans
No saved active plan yet.

Build a local protocol draft when you are ready.

Protocol draftsSchedule previewDaily log comparison
Create plan
ai conciergePreview chat

Daily copilot preview

Open
newsOpen News
Abstract clinical visualization of next-generation metabolic peptide pathways
Metabolic

Next-generation GLP-1s are moving from weight loss into broader metabolic positioning

A practical brief on how newer incretin combinations are changing the way metabolic peptide options are discussed.

Your Blueprint includes weight loss and hormonal context, so incretin updates are most useful when they are read as access, tolerability, and sequencing signals rather than as a dosing recommendation.
Clinical editorial image representing BPC-157 and recovery pathways
RecoveryBPC-157 remains a high-interest recovery topic, but evidence quality still needs context
Editorial image for GHK-Cu skin and tissue support context
SkinGHK-Cu sits across skin, hair, and recovery, which makes category boundaries important
Scientific editorial image for mitochondrial peptide and longevity context
LongevityMOTS-c keeps appearing in longevity conversations, but the signal is still early